ESMO® 2026 Highlights: Presenter Vignettes – Chantal Decroisette

Dr. Chantal Decroisette

Chantal Decroisette

MD

Centre Léon Bérard

2614O

Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC with PD-L1 ≥50%: PERSEE phase 3 trial (GFPC 01-2020)